US FDA approves Bluebird Bio’s gene therapy for rare neurological disorder
The approval was largely expected after the drug received unanimous endorsement from a panel of outside advisers to the FDA in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bluebird bio
Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat…
Abecma is a first-in-class BCMA-directed personalised immune cell therapy delivered as a one-time infusion for triple-class…
Cancer CART therapy: What are the benefits and stakes?
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
Hitachi Chemical Advanced Therapeutics Solutions, apceth Biopharma GmbH and bluebird bio to…
A commercial drug product manufacturing service agreement was also established between bluebird bio and apceth (which represents…
Bluebird bio, Bristol-Myers’ multiple myeloma therapy shows promise in early study
The lowest dose of the therapy, bb21217, had a median duration of response of 11.1 months and an overall response rate of 83 per…